Brecanavir

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBrecanavir
Drug Alias NameBrecanavirum布瑞那韦贝卡那韦VX-385GW-0385 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV protease inhibitors
TargetsHIV protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViiv Healthcare
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG